Biology subjects

Dimou, L.

Publications and source records attributed to Dimou, L..

4 recordsLinked to original sources

bioRxiv2025

Myelin density dictates region-specific vulnerability of oligodendrocyte lineage cells during aging

Aging of the central nervous system (CNS) leads to a progressive decline in numerous physiological functions. This decline can be attributed in part to alterations within the oligodendrocyte lineage, which comprises myelinating oligodendrocytes (OLs) and their progenitors, NG2-glia, that play a central role in maintaining homeostasis and ensuring proper myelin turnover. While NG2-glia are distributed throughout the CNS, OLs are enriched in highly myelinated regions, implying spatially heterogeneous requirements for NG2-glia proliferation and differentiation. Consequently, age-related impairments in these progenitor functions may differentially compromise oligodendrogenesis and myelin maintenance across distinct CNS compartments. Yet, the spatial and temporal dynamics of aging-associated alterations within the oligodendrocyte lineage remains insufficiently characterized. To address this gap, we investigated the effects of aging across three age groups in two anatomically adjacent but functionally distinct CNS regions, the cortical gray matter (GM) and the corpus callosum (CC). We demonstrated that aging is accompanied by a marked decline in the NG2-glia population. Aging NG2-glia displayed cell cycle dysregulation, characterized by reduced proliferative and differentiative capacity and accompanied by increased expression of cyclin-dependent kinase inhibitors (CDKIs), indicating disrupted homeostatic regulation. These alterations were most pronounced in highly myelinated regions, which also exhibited a stronger shift toward an age-associated inflammatory milieu. In parallel, we observed substantial accumulation of myelin debris and impaired phagocytic clearance in these myelin-dense areas. Moreover, we identified a selective loss of myelinating OLs in the CC, a phenomenon not detected in the gray matter (GM). Together, our findings delineate a tight interdependence between regional myelin density, inflammatory status, and the vulnerability of oligodendrocyte lineage cells to aging. These highlight multiple entry points of potential therapeutic intervention to mitigate CNS aging.

neuroscience↗

bioRxiv2025

Spreading alpha-Synuclein Oligomers Trigger Astrocyte Reactivity and Astrocyte-glutamatergic Neuron system dysfunction in an Age-Dependent Manner

BackgroundParkinsons disease (PD) is characterized by the progressive accumulation and spatio-temporal spread of -synuclein (-syn) oligomers and a progressive loss of dopaminergic neurons. Many studies showed a direct cytotoxic effect of -syn oligomers on neurons. Other cell types including astrocytes were also reported to show specific responses to -syn and are believed to play a role in the spreading of PD pathology. MethodsTo investigate the transcriptional and cellular consequences of -syn oligomer spreading, we employed spatial transcriptomics and single-nucleus RNA sequencing (snRNA-seq) in a transgenic PD mouse model expressing human -syn in neurons. We further compared our findings to published public snRNA-seq datasets from human PD patients ResultsOur analysis identified -syn spreading mostly to the substantia nigra and defined a transcriptional "Spreading Signature" associated with -syn pathology. We found an age correlated increase in astrocytes, close interactions between astrocytes and -syn, and transcriptional dysregulation of the astrocyte-glutamatergic neuron axis. We further identified two subtypes of glutamatergic neurons that are vulnerable to astrocytic changes. Comparative analysis with human PD snRNA-seq data showed concordant transcriptional changes related to astrocytic dysfunctions and diminished neuronal signaling. ConclusionBased on our results, we propose a model of -syn oligomer spreading involving astrocytes, glutamatergic synapses, and a disturbance in the astrocyte-glutamatergic neuron axis.

neuroscience↗

bioRxiv2025

ATXN2 polyglutamine expansion impairs QKI-dependent alternative splicing and oligodendrocyte maintenance

BackgroundPolyglutamine (polyQ) tract expansion mutations in Ataxin-2 gene (ATXN2) are associated with neurodegenerative diseases spinocerebellar ataxia type 2 (SCA2) and amyotrophic lateral sclerosis (ALS), while the therapeutic reduction of ATXN2 confers strong health-/lifespan extension in models of both disorders. Although the involvement of ATXN2 in peripheral lipid metabolism has been elaborated in Atxn2 knock-out mice, its impact on nervous system lipid maintenance and a potential influence on oligodendrocytes remains unexplored. MethodsWe examine the nervous tissue of an authentic ATXN2 polyQ expansion mouse model in terms of (i) gross morphology of the brain and differential glial affection via immunohistochemical analyses, (ii) spinocerebellar proteome profile via label-free mass spectroscopy and (iii) alternative splicing patterns of oligodendroglial transcripts via quantitative RT-PCR. Finally, electrophysiological recording of sensory response in cerebellar Purkinje cells was performed as a phenotypic measure of demyelination. ResultsWe demonstrate a massive impairment in myelin maintenance due to ATXN2 polyQ expansion, affecting key oligodendroglial proteins accompanied by their splicing anomalies much earlier than disease manifestation. Oligodendroglial ATXN2 aggregates were documented for the first time in cerebellum, which sequestrated the RNA splicing factor Quaking (QKI). As an outcome of demyelination, our SCA2 model showed a significant delay in response to sensory stimuli. ConclusionsOverall, we provide pioneer evidence of oligodendroglial proteotoxicity leading to myelin maintenance defects in an authentic mouse model of SCA2. Our findings suggest that not only neuronal metabolism, but also that of oligodendroglia depends on ATXN2 and is affected during the disease course. This novel aspect of ATXN2 pathomechanism sheds light on potential outcomes of its therapeutic manipulation, and makes it relevant also for demyelination syndromes next to SCA2 and other polyQ disorders.

neuroscience↗

bioRxiv2025

Neuropeptide CRH prevents premature differentiation of OPCs following CNS injury and in early postnatal development

The role of neuropeptides and their receptors in oligodendrocyte progenitor cells (OPCs) has largely been overlooked so far. Here, we describe a new subpopulation of corticotropin-releasing hormone (CRH)-expressing OPCs that aggregate around acute brain injuries and exhibit an elevated capacity to differentiate into myelinating oligodendrocytes (OLs). We found that CRH expression in OPCs is rapidly induced de novo as a transient response within the first 72 hours after injury. As target cells, we identified CRH receptor type 1 (CRHR1)-expressing OPCs which show a decreased differentiation velocity. We demonstrate that CRH/CRHR1 system inactivation increases the speed of OL generation compromising the long-term survival of OLs after acute injury. Furthermore, we prove that a CRH/CRHR1 system deficiency under non-injury conditions leads to increased early postnatal oligodendrogenesis and alterations in adult myelination. Altogether, we show that OPC-derived CRH not only actively influences the injury environment through the interaction with CRHR1-expressing OPCs, but also identify the G-protein coupled receptor CRHR1 as a critical modulator of oligodendrogenesis at early postnatal stages with lasting effects on adult myelination.

neuroscience↗